177 related articles for article (PubMed ID: 38720366)
41. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
42. High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer.
Zhang Y; Cheng S; Zhang M; Zhen L; Pang D; Zhang Q; Li Z
PLoS One; 2013; 8(9):e76147. PubMed ID: 24098773
[TBL] [Abstract][Full Text] [Related]
43. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count.
Li YL; Shi ZH; Wang X; Gu KS; Zhai ZM
BMC Cancer; 2019 Nov; 19(1):1049. PubMed ID: 31694577
[TBL] [Abstract][Full Text] [Related]
44. Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors.
Volodko N; Gutor T; Petronchak O; Huley R; Dúcka M; Šmarda J; Borsig L; Beneš P; Knopfová L
Sci Rep; 2019 Aug; 9(1):11634. PubMed ID: 31406165
[TBL] [Abstract][Full Text] [Related]
45. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis.
Li J; Xie Y; Wang X; Li F; Li S; Li M; Peng H; Yang L; Liu C; Pang L; Zou H; Zhao J; Qi Y; Cao Y; Hu J
Future Oncol; 2019 Jul; 15(19):2303-2317. PubMed ID: 31237146
[No Abstract] [Full Text] [Related]
47. Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy.
Taubert H; Eckstein M; Epple E; Jung R; Weigelt K; Lieb V; Sikic D; Stöhr R; Geppert C; Weyerer V; Bertz S; Kehlen A; Hartmann A; Wullich B; Wach S
Cells; 2021 Jan; 10(1):. PubMed ID: 33467469
[TBL] [Abstract][Full Text] [Related]
48. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
Guo B; Cen H; Tan X; Ke Q
BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
[TBL] [Abstract][Full Text] [Related]
49. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.
Shabo I; Olsson H; Sun XF; Svanvik J
Int J Cancer; 2009 Oct; 125(8):1826-31. PubMed ID: 19582880
[TBL] [Abstract][Full Text] [Related]
50. The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer.
Xu JY; Wang WS; Zhou J; Liu CY; Shi JL; Lu PH; Ding JL
Pancreas; 2019 Aug; 48(7):904-912. PubMed ID: 31268976
[TBL] [Abstract][Full Text] [Related]
51. Exploring the role CD163-labeled TAMs and FOXP3-labeled Tregs in different types of breast cancer: Reflections and putative benefits.
Shash LS; M Kamal KA; Abd Raboh NM
Indian J Pathol Microbiol; 2021; 64(1):28-37. PubMed ID: 33433406
[TBL] [Abstract][Full Text] [Related]
52. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
[TBL] [Abstract][Full Text] [Related]
54. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma.
Shiraishi D; Fujiwara Y; Horlad H; Saito Y; Iriki T; Tsuboki J; Cheng P; Nakagata N; Mizuta H; Bekki H; Nakashima Y; Oda Y; Takeya M; Komohara Y
Cancer Res; 2018 Jun; 78(12):3255-3266. PubMed ID: 29610117
[TBL] [Abstract][Full Text] [Related]
55. Immunocyte density in parathyroid carcinoma is correlated with disease relapse.
Hu Y; Cui M; Bi Y; Zhang X; Wang M; Hua S; Liao Q; Zhao Y
J Endocrinol Invest; 2020 Oct; 43(10):1453-1461. PubMed ID: 32219691
[TBL] [Abstract][Full Text] [Related]
56. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas.
Agarbati S; Mascitti M; Paolucci E; Togni L; Santarelli A; Rubini C; Fazioli F
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):359-365. PubMed ID: 32842026
[TBL] [Abstract][Full Text] [Related]
58. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas.
Lin MW; Yang CY; Kuo SW; Wu CT; Chang YL; Yang PC
Ann Surg Oncol; 2016 Sep; 23(9):3071-81. PubMed ID: 27150441
[TBL] [Abstract][Full Text] [Related]
59. CD163
Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
[TBL] [Abstract][Full Text] [Related]
60. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
Allison E; Edirimanne S; Matthews J; Fuller SJ
Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]